1 Study Coverage 1.1 COPD and Asthma Drug Devices Product Introduction 1.2 Global COPD and Asthma Drug Devices Outlook 2017 VS 2022 VS 2028 1.2.1 Global COPD and Asthma Drug Devices Sales in US$ Million for the Year 2017-2028 1.2.2 Global COPD and Asthma Drug Devices Sales in Volume for the Year 2017-2028 1.3 United States COPD and Asthma Drug Devices Outlook 2017 VS 2022 VS 2028 1.3.1 United States COPD and Asthma Drug Devices Sales in US$ Million for the Year 2017-2028 1.3.2 United States COPD and Asthma Drug Devices Sales in Volume for the Year 2017-2028 1.4 COPD and Asthma Drug Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States COPD and Asthma Drug Devices in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of COPD and Asthma Drug Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 COPD and Asthma Drug Devices Market Dynamics 1.5.1 COPD and Asthma Drug Devices Industry Trends 1.5.2 COPD and Asthma Drug Devices Market Drivers 1.5.3 COPD and Asthma Drug Devices Market Challenges 1.5.4 COPD and Asthma Drug Devices Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 COPD and Asthma Drug Devices Market Segment by Type 2.1.1 COPD & Asthma Inhaler 2.1.2 COPD & Asthma Nebulizer 2.2 Global COPD and Asthma Drug Devices Market Size by Type 2.2.1 Global COPD and Asthma Drug Devices Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global COPD and Asthma Drug Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global COPD and Asthma Drug Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States COPD and Asthma Drug Devices Market Size by Type 2.3.1 United States COPD and Asthma Drug Devices Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States COPD and Asthma Drug Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States COPD and Asthma Drug Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 COPD and Asthma Drug Devices Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.1.3 Others 3.2 Global COPD and Asthma Drug Devices Market Size by Application 3.2.1 Global COPD and Asthma Drug Devices Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global COPD and Asthma Drug Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global COPD and Asthma Drug Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States COPD and Asthma Drug Devices Market Size by Application 3.3.1 United States COPD and Asthma Drug Devices Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States COPD and Asthma Drug Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States COPD and Asthma Drug Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global COPD and Asthma Drug Devices Competitor Landscape by Company 4.1 Global COPD and Asthma Drug Devices Market Size by Company 4.1.1 Top Global COPD and Asthma Drug Devices Manufacturers Ranked by Revenue (2021) 4.1.2 Global COPD and Asthma Drug Devices Revenue by Manufacturer (2017-2022) 4.1.3 Global COPD and Asthma Drug Devices Sales by Manufacturer (2017-2022) 4.1.4 Global COPD and Asthma Drug Devices Price by Manufacturer (2017-2022) 4.2 Global COPD and Asthma Drug Devices Concentration Ratio (CR) 4.2.1 COPD and Asthma Drug Devices Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of COPD and Asthma Drug Devices in 2021 4.2.3 Global COPD and Asthma Drug Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global COPD and Asthma Drug Devices Manufacturing Base Distribution, Product Type 4.3.1 Global COPD and Asthma Drug Devices Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers COPD and Asthma Drug Devices Product Type 4.3.3 Date of International Manufacturers Enter into COPD and Asthma Drug Devices Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States COPD and Asthma Drug Devices Market Size by Company 4.5.1 Top COPD and Asthma Drug Devices Players in United States, Ranked by Revenue (2021) 4.5.2 United States COPD and Asthma Drug Devices Revenue by Players (2020, 2021 & 2022) 4.5.3 United States COPD and Asthma Drug Devices Sales by Players (2020, 2021 & 2022) 5 Global COPD and Asthma Drug Devices Market Size by Region 5.1 Global COPD and Asthma Drug Devices Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global COPD and Asthma Drug Devices Market Size in Volume by Region (2017-2028) 5.2.1 Global COPD and Asthma Drug Devices Sales in Volume by Region: 2017-2022 5.2.2 Global COPD and Asthma Drug Devices Sales in Volume Forecast by Region (2023-2028) 5.3 Global COPD and Asthma Drug Devices Market Size in Value by Region (2017-2028) 5.3.1 Global COPD and Asthma Drug Devices Sales in Value by Region: 2017-2022 5.3.2 Global COPD and Asthma Drug Devices Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America COPD and Asthma Drug Devices Market Size YoY Growth 2017-2028 6.1.2 North America COPD and Asthma Drug Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific COPD and Asthma Drug Devices Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific COPD and Asthma Drug Devices Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe COPD and Asthma Drug Devices Market Size YoY Growth 2017-2028 6.3.2 Europe COPD and Asthma Drug Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America COPD and Asthma Drug Devices Market Size YoY Growth 2017-2028 6.4.2 Latin America COPD and Asthma Drug Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa COPD and Asthma Drug Devices Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa COPD and Asthma Drug Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Novartis International AG 7.1.1 Novartis International AG Corporation Information 7.1.2 Novartis International AG Description and Business Overview 7.1.3 Novartis International AG COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Novartis International AG COPD and Asthma Drug Devices Products Offered 7.1.5 Novartis International AG Recent Development 7.2 Merck 7.2.1 Merck Corporation Information 7.2.2 Merck Description and Business Overview 7.2.3 Merck COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Merck COPD and Asthma Drug Devices Products Offered 7.2.5 Merck Recent Development 7.3 AstraZeneca 7.3.1 AstraZeneca Corporation Information 7.3.2 AstraZeneca Description and Business Overview 7.3.3 AstraZeneca COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.3.4 AstraZeneca COPD and Asthma Drug Devices Products Offered 7.3.5 AstraZeneca Recent Development 7.4 GlaxoSmithKline 7.4.1 GlaxoSmithKline Corporation Information 7.4.2 GlaxoSmithKline Description and Business Overview 7.4.3 GlaxoSmithKline COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.4.4 GlaxoSmithKline COPD and Asthma Drug Devices Products Offered 7.4.5 GlaxoSmithKline Recent Development 7.5 3M Healthcare 7.5.1 3M Healthcare Corporation Information 7.5.2 3M Healthcare Description and Business Overview 7.5.3 3M Healthcare COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.5.4 3M Healthcare COPD and Asthma Drug Devices Products Offered 7.5.5 3M Healthcare Recent Development 7.6 GF Health Products, Inc 7.6.1 GF Health Products, Inc Corporation Information 7.6.2 GF Health Products, Inc Description and Business Overview 7.6.3 GF Health Products, Inc COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.6.4 GF Health Products, Inc COPD and Asthma Drug Devices Products Offered 7.6.5 GF Health Products, Inc Recent Development 7.7 Sunovion Pharmaceuticals Inc. 7.7.1 Sunovion Pharmaceuticals Inc. Corporation Information 7.7.2 Sunovion Pharmaceuticals Inc. Description and Business Overview 7.7.3 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Products Offered 7.7.5 Sunovion Pharmaceuticals Inc. Recent Development 7.8 Smith Medicals, Inc. 7.8.1 Smith Medicals, Inc. Corporation Information 7.8.2 Smith Medicals, Inc. Description and Business Overview 7.8.3 Smith Medicals, Inc. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Smith Medicals, Inc. COPD and Asthma Drug Devices Products Offered 7.8.5 Smith Medicals, Inc. Recent Development 7.9 Baxter International 7.9.1 Baxter International Corporation Information 7.9.2 Baxter International Description and Business Overview 7.9.3 Baxter International COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Baxter International COPD and Asthma Drug Devices Products Offered 7.9.5 Baxter International Recent Development 7.10 Koninklijke Philips N.V. 7.10.1 Koninklijke Philips N.V. Corporation Information 7.10.2 Koninklijke Philips N.V. Description and Business Overview 7.10.3 Koninklijke Philips N.V. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Koninklijke Philips N.V. COPD and Asthma Drug Devices Products Offered 7.10.5 Koninklijke Philips N.V. Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 COPD and Asthma Drug Devices Industry Chain Analysis 8.2 COPD and Asthma Drug Devices Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 COPD and Asthma Drug Devices Distributors 8.3 COPD and Asthma Drug Devices Production Mode & Process 8.4 COPD and Asthma Drug Devices Sales and Marketing 8.4.1 COPD and Asthma Drug Devices Sales Channels 8.4.2 COPD and Asthma Drug Devices Distributors 8.5 COPD and Asthma Drug Devices Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. COPD and Asthma Drug Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. COPD and Asthma Drug Devices Market Trends Table 3. COPD and Asthma Drug Devices Market Drivers Table 4. COPD and Asthma Drug Devices Market Challenges Table 5. COPD and Asthma Drug Devices Market Restraints Table 6. Global COPD and Asthma Drug Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States COPD and Asthma Drug Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global COPD and Asthma Drug Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States COPD and Asthma Drug Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top COPD and Asthma Drug Devices Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global COPD and Asthma Drug Devices Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global COPD and Asthma Drug Devices Revenue Share by Manufacturer, 2017-2022 Table 13. Global COPD and Asthma Drug Devices Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global COPD and Asthma Drug Devices Sales Share by Manufacturer, 2017-2022 Table 15. Global COPD and Asthma Drug Devices Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global COPD and Asthma Drug Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global COPD and Asthma Drug Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD and Asthma Drug Devices as of 2021) Table 18. Top Players of COPD and Asthma Drug Devices in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers COPD and Asthma Drug Devices Product Type Table 20. Date of International Manufacturers Enter into COPD and Asthma Drug Devices Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top COPD and Asthma Drug Devices Players in United States Market, Ranking by Revenue (2021) Table 23. United States COPD and Asthma Drug Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States COPD and Asthma Drug Devices Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States COPD and Asthma Drug Devices Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States COPD and Asthma Drug Devices Sales Share by Players, 2020, 2021 & 2022 Table 27. Global COPD and Asthma Drug Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global COPD and Asthma Drug Devices Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global COPD and Asthma Drug Devices Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global COPD and Asthma Drug Devices Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global COPD and Asthma Drug Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America COPD and Asthma Drug Devices Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America COPD and Asthma Drug Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific COPD and Asthma Drug Devices Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific COPD and Asthma Drug Devices Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe COPD and Asthma Drug Devices Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe COPD and Asthma Drug Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America COPD and Asthma Drug Devices Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa COPD and Asthma Drug Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa COPD and Asthma Drug Devices Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa COPD and Asthma Drug Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Novartis International AG Corporation Information Table 43. Novartis International AG Description and Business Overview Table 44. Novartis International AG COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Novartis International AG COPD and Asthma Drug Devices Product Table 46. Novartis International AG Recent Development Table 47. Merck Corporation Information Table 48. Merck Description and Business Overview Table 49. Merck COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Merck Product Table 51. Merck Recent Development Table 52. AstraZeneca Corporation Information Table 53. AstraZeneca Description and Business Overview Table 54. AstraZeneca COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. AstraZeneca Product Table 56. AstraZeneca Recent Development Table 57. GlaxoSmithKline Corporation Information Table 58. GlaxoSmithKline Description and Business Overview Table 59. GlaxoSmithKline COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. GlaxoSmithKline Product Table 61. GlaxoSmithKline Recent Development Table 62. 3M Healthcare Corporation Information Table 63. 3M Healthcare Description and Business Overview Table 64. 3M Healthcare COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. 3M Healthcare Product Table 66. 3M Healthcare Recent Development Table 67. GF Health Products, Inc Corporation Information Table 68. GF Health Products, Inc Description and Business Overview Table 69. GF Health Products, Inc COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. GF Health Products, Inc Product Table 71. GF Health Products, Inc Recent Development Table 72. Sunovion Pharmaceuticals Inc. Corporation Information Table 73. Sunovion Pharmaceuticals Inc. Description and Business Overview Table 74. Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Sunovion Pharmaceuticals Inc. Product Table 76. Sunovion Pharmaceuticals Inc. Recent Development Table 77. Smith Medicals, Inc. Corporation Information Table 78. Smith Medicals, Inc. Description and Business Overview Table 79. Smith Medicals, Inc. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Smith Medicals, Inc. Product Table 81. Smith Medicals, Inc. Recent Development Table 82. Baxter International Corporation Information Table 83. Baxter International Description and Business Overview Table 84. Baxter International COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Baxter International Product Table 86. Baxter International Recent Development Table 87. Koninklijke Philips N.V. Corporation Information Table 88. Koninklijke Philips N.V. Description and Business Overview Table 89. Koninklijke Philips N.V. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Koninklijke Philips N.V. Product Table 91. Koninklijke Philips N.V. Recent Development Table 92. Key Raw Materials Lists Table 93. Raw Materials Key Suppliers Lists Table 94. COPD and Asthma Drug Devices Customers List Table 95. COPD and Asthma Drug Devices Distributors List Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. COPD and Asthma Drug Devices Product Picture Figure 2. Global COPD and Asthma Drug Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global COPD and Asthma Drug Devices Market Size 2017-2028 (US$ Million) Figure 4. Global COPD and Asthma Drug Devices Sales 2017-2028 (K Units) Figure 5. United States COPD and Asthma Drug Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States COPD and Asthma Drug Devices Market Size 2017-2028 (US$ Million) Figure 7. United States COPD and Asthma Drug Devices Sales 2017-2028 (K Units) Figure 8. United States COPD and Asthma Drug Devices Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States COPD and Asthma Drug Devices Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. COPD and Asthma Drug Devices Report Years Considered Figure 11. Product Picture of COPD & Asthma Inhaler Figure 12. Product Picture of COPD & Asthma Nebulizer Figure 13. Global COPD and Asthma Drug Devices Market Share by Type in 2022 & 2028 Figure 14. Global COPD and Asthma Drug Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global COPD and Asthma Drug Devices Sales Market Share in Value by Type (2017-2028) Figure 16. Global COPD and Asthma Drug Devices Sales by Type (2017-2028) & (K Units) Figure 17. Global COPD and Asthma Drug Devices Sales Market Share in Volume by Type (2017-2028) Figure 18. Global COPD and Asthma Drug Devices Price by Type (2017-2028) & (USD/Unit) Figure 19. United States COPD and Asthma Drug Devices Market Share by Type in 2022 & 2028 Figure 20. United States COPD and Asthma Drug Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States COPD and Asthma Drug Devices Sales Market Share in Value by Type (2017-2028) Figure 22. United States COPD and Asthma Drug Devices Sales by Type (2017-2028) & (K Units) Figure 23. United States COPD and Asthma Drug Devices Sales Market Share in Volume by Type (2017-2028) Figure 24. United States COPD and Asthma Drug Devices Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Hospitals Figure 26. Product Picture of Clinics Figure 27. Product Picture of Others Figure 28. Global COPD and Asthma Drug Devices Market Share by Application in 2022 & 2028 Figure 29. Global COPD and Asthma Drug Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global COPD and Asthma Drug Devices Sales Market Share in Value by Application (2017-2028) Figure 31. Global COPD and Asthma Drug Devices Sales by Application (2017-2028) & (K Units) Figure 32. Global COPD and Asthma Drug Devices Sales Market Share in Volume by Application (2017-2028) Figure 33. Global COPD and Asthma Drug Devices Price by Application (2017-2028) & (USD/Unit) Figure 34. United States COPD and Asthma Drug Devices Market Share by Application in 2022 & 2028 Figure 35. United States COPD and Asthma Drug Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States COPD and Asthma Drug Devices Sales Market Share in Value by Application (2017-2028) Figure 37. United States COPD and Asthma Drug Devices Sales by Application (2017-2028) & (K Units) Figure 38. United States COPD and Asthma Drug Devices Sales Market Share in Volume by Application (2017-2028) Figure 39. United States COPD and Asthma Drug Devices Price by Application (2017-2028) & (USD/Unit) Figure 40. North America COPD and Asthma Drug Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America COPD and Asthma Drug Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe COPD and Asthma Drug Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe COPD and Asthma Drug Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific COPD and Asthma Drug Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific COPD and Asthma Drug Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Taiwan COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Philippines COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America COPD and Asthma Drug Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America COPD and Asthma Drug Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa COPD and Asthma Drug Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 69. Middle East & Africa COPD and Asthma Drug Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. U.A.E COPD and Asthma Drug Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. COPD and Asthma Drug Devices Value Chain Figure 74. COPD and Asthma Drug Devices Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Novartis International AG Merck AstraZeneca GlaxoSmithKline 3M Healthcare GF Health Products, Inc Sunovion Pharmaceuticals Inc. Smith Medicals, Inc. Baxter International Koninklijke Philips N.V.